Hematopoietic/Lymphoid Cancer Recruiting Phase 1 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03132454Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory LeukemiaTreatment
NCT03283917Daratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisTreatment